Browse the latest research summaries in the field of healthcare for spinal cord injury patients and caregivers.
Showing 421-430 of 432 results
The Journal of Spinal Cord Medicine, 2021 • January 1, 2021
This cost-utility analysis suggests that virtual illusion (VI) combined with transcranial direct current stimulation (tDCS) may be more cost-effective than tDCS alone for treating neuropathic pain (NP...
KEY FINDING: VI and tDCS therapy costs $3,396 per QALY compared to standard care.
J. Clin. Med., 2022 • July 13, 2022
This study investigates the application of artificial intelligence-based algorithms to predict prolonged hospital length of stay (LOS) after lumbar decompression surgery. The findings suggest that mac...
KEY FINDING: Machine learning and deep learning algorithms can predict whether patients will experience an increased LOS following lumbar decompression surgery.
J. Pers. Med., 2022 • September 10, 2022
The discovery of iPSCs has provided a new roadmap for clinical translation research and regeneration therapy. The role of human iPSCs in scientific research was examined and the most common neurodegen...
KEY FINDING: Parkinson’s disease scored highest in iPSC-related research publications, followed by Alzheimer’s disease, based on a PUBMED literature review.
Antibiotics, 2022 • December 13, 2022
This retrospective study evaluated urine cultures from a rural hospital in Ghana between October 2019 and December 2021 to assess antimicrobial resistance (AMR) rates of uropathogens. The study found ...
KEY FINDING: Escherichia coli was the most frequently identified bacterial species in positive urine cultures, representing 42.7% of cases.
Neural Regeneration Research, 2024 • August 14, 2023
This retrospective study examined the epidemiological and clinical features, treatment status, and economic burden of traumatic spinal cord injury in China at the national level. The percentage of tra...
KEY FINDING: The percentage of TSCIs among all hospitalized patients did not significantly change overall from 2013-2018.
Genome Medicine, 2023 • December 2, 2023
The study introduces comboSC, a computational prototype for personalized cancer combination therapy optimization using single-cell transcriptomes. ComboSC stratifies individual patient samples based o...
KEY FINDING: ComboSC can predict potential drug combinations for experimental validation and clinical usage using the single-cell transcriptome.
The Journal of Spinal Cord Medicine, 2025 • January 26, 2024
This study investigated age-based differences among TSCI inpatients in China, focusing on demographic and clinical characteristics, treatment status, and economic burden. The study found that the numb...
KEY FINDING: The number and proportion of elderly TSCI patients are increasing in China.
Neuropsychiatric Disease and Treatment, 2016 • August 31, 2016
The article "Effect of low-energy extracorporeal shock wave on vascular regeneration after spinal cord injury and the recovery of motor function" has been retracted. The reason for the retraction is t...
KEY FINDING: The original article plagiarized content from a 2014 publication in the Journal of Neurosurgery.
Frontiers in Surgery, 2016 • November 8, 2016
Spinal cord injury is a serious and debilitating injury with limited treatment resources. After the initial injury to the spinal cord, numerous secondary pathophysiological events occur that contribut...
KEY FINDING: miRNAs play a pivotal role in the shift from hypertrophy to hyperplasia in astrogliosis. Specifically, miR-21 is highly expressed in astrocytes near and at the lesion site during astrogliosis and is directly responsible for the shift from hypertrophy to hyperplasia, where it suppresses GFAP and VIM.
Epilepsia Open, 2017 • October 1, 2017
Adverse events are a concern in epilepsy monitoring units (EMUs) during long-term video EEG, with rates up to 10% of patients. This study assessed the effectiveness of a personalized safety protocol i...
KEY FINDING: The implementation of a personalized safety protocol reduced the overall adverse event rate from 9% to 5%.